Nevertheless, chronic osteomyelitis, particularly when debridement had been possible, frequently improved on dalbavancin as judged subjectively by reduced pain, lessening of discharge and improved mobility as well as objectively, in some cases, by CRP trend and lack of radiologically visible disease progression. The gene discussed is CRP; the disease is osteomyelitis.